Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 66

1.

ERS statement on standardisation of cardiopulmonary exercise testing in chronic lung diseases.

Radtke T, Crook S, Kaltsakas G, Louvaris Z, Berton D, Urquhart DS, Kampouras A, Rabinovich RA, Verges S, Kontopidis D, Boyd J, Tonia T, Langer D, De Brandt J, Goërtz YMJ, Burtin C, Spruit MA, Braeken DCW, Dacha S, Franssen FME, Laveneziana P, Eber E, Troosters T, Neder JA, Puhan MA, Casaburi R, Vogiatzis I, Hebestreit H.

Eur Respir Rev. 2019 Dec 18;28(154). pii: 180101. doi: 10.1183/16000617.0101-2018. Print 2019 Dec 31. Review.

2.

Practical challenges of diagnosing obstruction in the presence of restriction.

Neder JA, O'Donnell DE, Berton DC.

J Bras Pneumol. 2019 Dec 13;45(5):e20190318. doi: 10.1590/1806-3713/e20190318. English, Portuguese. No abstract available.

3.

Exertional dyspnoea-ventilation relationship to discriminate respiratory from cardiac impairment.

Plachi F, Balzan FM, Fröhlich LF, Gass R, Mendes NB, Schroeder E, Berton DC, O'Donnell DE, Neder JA.

Eur Respir J. 2019 Nov 19. pii: 1901518. doi: 10.1183/13993003.01518-2019. [Epub ahead of print] No abstract available.

PMID:
31744838
4.

The role of evaluating inspiratory constraints and ventilatory inefficiency in the investigation of dyspnea of unclear etiology.

Neder JA, Berton DC, Marillier M, Bernard AC, O Donnell DE; Canadian Respiratory Research Network.

Respir Med. 2019 Oct - Nov;158:6-13. doi: 10.1016/j.rmed.2019.09.007. Epub 2019 Sep 12.

PMID:
31541929
5.

Effects of lung deflation induced by tiotropium/olodaterol on the cardiocirculatory responses to exertion in COPD.

Berton DC, Marques RD, Palmer B, O'Donnell DE, Neder JA.

Respir Med. 2019 Oct;157:59-68. doi: 10.1016/j.rmed.2019.09.006. Epub 2019 Sep 10.

PMID:
31522031
6.

Why we should never ignore an "isolated" low lung diffusing capacity.

Neder JA, Berton DC, O'Donnell DE.

J Bras Pneumol. 2019 Sep 5;45(4):e20190241. doi: 10.1590/1806-3713/e20190241. English, Portuguese. No abstract available.

7.

Tidal Flow-Volume Loop Enveloping at Rest in Advanced COPD.

Fröhlich LF, Balzan FM, Plachi F, Gass R, Mendes NBS, da Silva DP Jr, Sanches PRS, Knorst MM, Neder JA, Berton DC.

Respir Care. 2019 Dec;64(12):1488-1499. doi: 10.4187/respcare.06787. Epub 2019 Aug 27.

PMID:
31455685
8.

Inspiratory Constraints and Ventilatory Inefficiency Are Superior to Breathing Reserve in the Assessment of Exertional Dyspnea in COPD.

Neder JA, Berton DC, Marillier M, Bernard AC, O'Donnell DE; Canadian Respiratory Research Network.

COPD. 2019 Apr;16(2):174-181. doi: 10.1080/15412555.2019.1631776. Epub 2019 Jul 5. Erratum in: COPD. 2019 Dec;16(5-6):429.

PMID:
31272243
9.

Uncovering the beneficial effects of inhaled bronchodilator in COPD: beyond forced spirometry.

Neder JA, Berton DC, O'Donnell DE.

J Bras Pneumol. 2019 Jun 27;45(3):e20190168. doi: 10.1590/1806-3713/e20190168. English, Portuguese. No abstract available.

10.

Clinical and Physiologic Implications of Negative Cardiopulmonary Interactions in Coexisting Chronic Obstructive Pulmonary Disease-Heart Failure.

Neder JA, Rocha A, Berton DC, O'Donnell DE.

Clin Chest Med. 2019 Jun;40(2):421-438. doi: 10.1016/j.ccm.2019.02.006. Review.

PMID:
31078219
11.

Incorporating Lung Diffusing Capacity for Carbon Monoxide in Clinical Decision Making in Chest Medicine.

Neder JA, Berton DC, Muller PT, O'Donnell DE.

Clin Chest Med. 2019 Jun;40(2):285-305. doi: 10.1016/j.ccm.2019.02.005. Review.

PMID:
31078210
12.

Measuring slow vital capacity to detect airflow limitation in a woman with dyspnea and a preserved FEV1/FVC ratio.

Berton DC, Neder JA.

J Bras Pneumol. 2019 Apr 25;45(2):e20190084. doi: 10.1590/1806-3713/e20190084. English, Portuguese. No abstract available.

13.

Is the Slow Vital Capacity Clinically Useful to Uncover Airflow Limitation in Subjects With Preserved FEV1/FVC Ratio?

Saint-Pierre M, Ladha J, Berton DC, Reimao G, Castelli G, Marillier M, Bernard AC, O'Donnell DE, Neder JA.

Chest. 2019 Sep;156(3):497-506. doi: 10.1016/j.chest.2019.02.001. Epub 2019 Feb 12.

PMID:
30768928
14.

Method development and validation of ursodiol and its major metabolites in human plasma by HPLC-tandem mass spectrometry.

Pinto MC, Berton DC, de Oliveira AC, Lazaro CM, Carandina SAC.

Clin Pharmacol. 2019 Jan 4;11:1-13. doi: 10.2147/CPAA.S187519. eCollection 2019.

15.

Sensory consequences of critical inspiratory constraints during exercise in pulmonary arterial hypertension.

Dorneles RG, Plachi F, Gass R, Toniazzo VT, Thome P, Sanches PR, Gazzana MB, Neder JA, Berton DC.

Respir Physiol Neurobiol. 2019 Mar;261:40-47. doi: 10.1016/j.resp.2019.01.002. Epub 2019 Jan 7.

PMID:
30630111
16.

Current challenges in managing comorbid heart failure and COPD.

Neder JA, Rocha A, Alencar MCN, Arbex F, Berton DC, Oliveira MF, Sperandio PA, Nery LE, O'Donnell DE.

Expert Rev Cardiovasc Ther. 2018 Sep;16(9):653-673. doi: 10.1080/14779072.2018.1510319. Epub 2018 Sep 3. Review.

PMID:
30099925
17.

Low exertional inspiratory capacity is not related to dynamic inspiratory muscle weakness in heart failure.

Plachi F, Balzan FM, Gass R, Dorneles RG, Zambiazi R, da Silva DP, Sanches PR, Clausell NO, Berton DC.

Respir Physiol Neurobiol. 2018 Aug;254:32-35. doi: 10.1016/j.resp.2018.04.005. Epub 2018 Apr 16.

18.

Systemic vascular dysfunction is associated with emphysema burden in mild COPD.

Zelt JT, Jones JH, Hirai DM, King TJ, Berton DC, Pyke KE, O'Donnell DE, Neder JA.

Respir Med. 2018 Mar;136:29-36. doi: 10.1016/j.rmed.2018.01.007. Epub 2018 Jan 12.

PMID:
29501244
19.

A Simplified Approach to Select Exercise Endurance Intensity for Interventional Studies in COPD.

Degani-Costa LH, O'Donnell DE, Webb K, Aranda LC, Carlstron JP, Cesar TDS, Plachi F, Berton DC, Neder JA, Nery LE.

COPD. 2018 Apr;15(2):139-147. doi: 10.1080/15412555.2018.1428944. Epub 2018 Feb 27.

PMID:
29485343
20.

Pulmonary Rehabilitation in Patients With Advanced Idiopathic Pulmonary Fibrosis Referred for Lung Transplantation.

da Fontoura FF, Berton DC, Watte G, Florian J, Schio SM, Camargo JJP, Teixeira PJZ, Moreira JDS.

J Cardiopulm Rehabil Prev. 2018 Mar;38(2):131-134. doi: 10.1097/HCR.0000000000000315.

PMID:
29465499
21.

Characteristics associated with mortality in patients with chronic obstructive pulmonary disease (COPD)-heart failure coexistence.

Plachi F, Balzan FM, Sanseverino RA, Palombini DV, Marques RD, Clausell NO, Knorst MM, Neder JA, Berton DC.

Prim Health Care Res Dev. 2018 Nov;19(6):570-574. doi: 10.1017/S1463423618000117. Epub 2018 Feb 21.

22.

Excess ventilation in COPD: Implications for dyspnoea and tolerance to interval exercise.

Bravo DM, Gimenes AC, Amorim BC, Alencar MC, Berton DC, O'Donnell DE, Nery LE, Neder JA.

Respir Physiol Neurobiol. 2018 Apr;250:7-13. doi: 10.1016/j.resp.2018.01.013. Epub 2018 Jan 31.

PMID:
29382565
23.

Limiting Factors in Walking Performance of Subjects With COPD.

Sanseverino MA, Pecchiari M, Bona RL, Berton DC, de Queiroz FB, Gruet M, Peyré-Tartaruga LA.

Respir Care. 2018 Mar;63(3):301-310. doi: 10.4187/respcare.05768. Epub 2017 Nov 21.

24.

Effects of Expiratory Positive Airway Pressure on Exercise Tolerance, Dynamic Hyperinflation, and Dyspnea in COPD.

Gass R, Merola P, Monteiro MB, Cardoso DM, Paiva DN, Teixeira PJ, Knorst MM, Berton DC.

Respir Care. 2017 Oct;62(10):1298-1306. doi: 10.4187/respcare.05556. Epub 2017 Aug 1.

25.

Effectiveness assessment of a guideline based protocol for ventilatory support management of COPD exacerbations in an emergency department.

Plachi F, Vieira FN, Berton DC, Knorst M, Dias AS, Balzan FM.

Braz J Phys Ther. 2017 Sep - Oct;21(5):357-364. doi: 10.1016/j.bjpt.2017.06.005. Epub 2017 Jul 5.

26.

Excess Ventilation in Chronic Obstructive Pulmonary Disease-Heart Failure Overlap. Implications for Dyspnea and Exercise Intolerance.

Rocha A, Arbex FF, Sperandio PA, Souza A, Biazzim L, Mancuso F, Berton DC, Hochhegger B, Alencar MCN, Nery LE, O'Donnell DE, Neder JA.

Am J Respir Crit Care Med. 2017 Nov 15;196(10):1264-1274. doi: 10.1164/rccm.201704-0675OC.

PMID:
28665692
27.

Ventilatory Inefficiency and Exertional Dyspnea in Early Chronic Obstructive Pulmonary Disease.

Neder JA, Berton DC, Müller PT, Elbehairy AF, Rocha A, Palange P, O'Donnell DE; Canadian Respiratory Research Network.

Ann Am Thorac Soc. 2017 Jul;14(Supplement_1):S22-S29. doi: 10.1513/AnnalsATS.201612-1033FR. Review.

PMID:
28345959
28.

Advances in the Evaluation of Respiratory Pathophysiology during Exercise in Chronic Lung Diseases.

O'Donnell DE, Elbehairy AF, Berton DC, Domnik NJ, Neder JA.

Front Physiol. 2017 Feb 22;8:82. doi: 10.3389/fphys.2017.00082. eCollection 2017. Review.

29.

Physiological and clinical relevance of exercise ventilatory efficiency in COPD.

Neder JA, Berton DC, Arbex FF, Alencar MC, Rocha A, Sperandio PA, Palange P, O'Donnell DE.

Eur Respir J. 2017 Mar 8;49(3). pii: 1602036. doi: 10.1183/13993003.02036-2016. Print 2017 Mar. Review.

30.

Maximal Inspiratory Pressure: Does the Choice of Reference Values Actually Matter?

Rodrigues A, Da Silva ML, Berton DC, Cipriano G Jr, Pitta F, O'Donnell DE, Neder JA.

Chest. 2017 Jul;152(1):32-39. doi: 10.1016/j.chest.2016.11.045. Epub 2016 Dec 8.

PMID:
27940276
31.

Effects of indacaterol versus tiotropium on exercise tolerance in patients with moderate COPD: a pilot randomized crossover study.

Berton DC, Santos ÁH, Bohn I Jr, Lima RQ, Breda V, Teixeira PJ.

J Bras Pneumol. 2016 Sep-Oct;42(5):367-373. doi: 10.1590/S1806-37562015000000334. English, Portuguese.

32.

Does Exercise Ventilatory Inefficiency Predict Poor Outcome in Heart Failure Patients With COPD?

Alencar MC, Arbex FF, Souza A, Mazzuco A, Sperandio PA, Rocha A, Hirai DM, Mancuso F, Berton DC, Borghi-Silva A, Almeida D, OʼDonnel DE, Neder JA.

J Cardiopulm Rehabil Prev. 2016 Nov/Dec;36(6):454-459.

PMID:
27779551
33.

Physiological and sensory consequences of exercise oscillatory ventilation in heart failure-COPD.

Rocha A, Arbex FF, Alencar MC, Sperandio PA, Hirai DM, Berton DC, O'Donnell DE, Neder JA.

Int J Cardiol. 2016 Dec 1;224:447-453. doi: 10.1016/j.ijcard.2016.09.077. Epub 2016 Sep 24.

PMID:
27701063
34.

A 56-Year-Old, Otherwise Healthy Woman Presenting With Light-headedness and Progressive Shortness of Breath.

Neder JA, Hirai DM, Jones JH, Zelt JT, Berton DC, O'Donnell DE.

Chest. 2016 Jul;150(1):e23-7. doi: 10.1016/j.chest.2016.02.672.

PMID:
27396797
35.

Exercise Ventilation in COPD: Influence of Systolic Heart Failure.

Arbex FF, Alencar MC, Souza A, Mazzuco A, Sperandio PA, Rocha A, Hirai DM, Mancuso F, Berton DC, Borghi-Silva A, Almeida DR, O'Donnell DE, Neder JA.

COPD. 2016 Dec;13(6):693-699. Epub 2016 May 12.

PMID:
27172093
36.

Exercise Ventilatory Inefficiency Adds to Lung Function in Predicting Mortality in COPD.

Neder JA, Alharbi A, Berton DC, Alencar MC, Arbex FF, Hirai DM, Webb KA, O'Donnell DE.

COPD. 2016 Aug;13(4):416-24. doi: 10.3109/15412555.2016.1158801. Epub 2016 Apr 14.

PMID:
27077955
37.

Insights into ventilation-gas exchange coupling in chronic thromboembolic pulmonary hypertension.

Neder JA, Ramos RP, Ota-Arakaki JS, Ferreira EM, Hirai DM, Sperandio PA, Alencar MC, Arbex FF, Berton DC, D'Arsigny C, O'Donnell DE.

Eur Respir J. 2016 Jul;48(1):252-4. doi: 10.1183/13993003.01948-2015. Epub 2016 Apr 13. No abstract available.

38.

Inspiratory loading and limb blood flow in COPD: The modulating effects of resting lung hyperinflation.

Berton DC, de Castro MA, Merola P, Benedetto I, Castilho M, Vieira PJ, Knorst MM, Neder JA.

Respir Physiol Neurobiol. 2016 Jul;228:25-9. doi: 10.1016/j.resp.2016.03.004. Epub 2016 Mar 7.

39.

Effects of diaphragmatic contraction on lower limb venous return and central hemodynamic parameters contrasting healthy subjects versus heart failure patients at rest and during exercise.

Balzan FM, da Silva RC, da Silva DP, Sanches PR, Tavares AM, Ribeiro JP, Berton DC, Clausell NO.

Physiol Rep. 2014 Dec 11;2(12). pii: e12216. doi: 10.14814/phy2.12216. Print 2014 Dec 1.

40.

Quantitative versus qualitative cultures of respiratory secretions for clinical outcomes in patients with ventilator-associated pneumonia.

Berton DC, Kalil AC, Teixeira PJ.

Cochrane Database Syst Rev. 2014 Oct 30;(10):CD006482. doi: 10.1002/14651858.CD006482.pub4. Review.

PMID:
25354013
41.

The relationship between fat-free mass index and pulmonary hyperinflation in COPD patients.

Silveira L, Teixeira PJ, da Costa CC, de Souza RM, Merola PK, Colombo C, Marques RD, Berton DC.

Respirology. 2014 Nov;19(8):1204-8. doi: 10.1111/resp.12406.

42.

The effects of dynamic hyperinflation on CT emphysema measurements in patients with COPD.

Alves GRT, Marchiori E, Irion KL, Teixeira PJZ, Berton DC, Rubin AS, Hochhegger B.

Eur J Radiol. 2014 Dec;83(12):2255-2259. doi: 10.1016/j.ejrad.2014.08.014. Epub 2014 Sep 2.

PMID:
25271068
43.

Can bronchodilators improve exercise tolerance in COPD patients without dynamic hyperinflation?

Scuarcialupi ME, Berton DC, Cordoni PK, Squassoni SD, Fiss E, Neder JA.

J Bras Pneumol. 2014 Mar-Apr;40(2):111-8. English, Portuguese.

44.

Exercise capacity in adolescent and adult patients with post infectious bronchiolitis obliterans.

Frohlich LF, Vieira PJ, Teixeira PJ, Silva FA, Ribeiro JP, Berton DC.

Pediatr Pulmonol. 2014 Sep;49(9):911-8. doi: 10.1002/ppul.22929. Epub 2013 Dec 23.

PMID:
24375976
45.

Inspiratory resistance decreases limb blood flow in COPD patients with heart failure.

Chiappa GR, Vieira PJ, Umpierre D, Corrêa AP, Berton DC, Ribeiro JP, Neder JA.

Eur Respir J. 2014 May;43(5):1507-10. doi: 10.1183/09031936.00166013. Epub 2013 Nov 14. No abstract available.

46.

Determination of anaerobic threshold through heart rate and near infrared spectroscopy in elderly healthy men.

Reis MS, Berton DC, Arena R, Catai AM, Neder JA, Borghi-Silva A.

Braz J Phys Ther. 2013 Sep-Oct;17(5):506-15. doi: 10.1590/S1413-35552012005000115. Epub 2013 Oct 21.

PMID:
24173351
47.

The authors respond.

Monteiro MB, Berton DC, Teixeira PJ.

Respir Care. 2013 Mar;58(3):e34-5. No abstract available.

48.

Effects of bicarbonate on oxyhaemoglobin desaturation and exercise performance in athletes.

Do Valle Bargieri J, Berton DC, Aparecido De Almeida A, Asprón Garcia F, Carlos Da Silva A, Alberto Neder J, Andrade MS.

J Sports Med Phys Fitness. 2013 Oct;53(5):470-6.

PMID:
23903526
49.

Effectiveness of pulmonary rehabilitation in exercise capacity and quality of life in chronic obstructive pulmonary disease patients with and without global fat-free mass depletion.

Berton DC, Silveira L, Da Costa CC, De Souza RM, Winter CD, Zimermann Teixeira PJ.

Arch Phys Med Rehabil. 2013 Aug;94(8):1607-14. doi: 10.1016/j.apmr.2013.02.005. Epub 2013 Feb 14.

PMID:
23416765
50.

Sildenafil improves microvascular O2 delivery-to-utilization matching and accelerates exercise O2 uptake kinetics in chronic heart failure.

Sperandio PA, Oliveira MF, Rodrigues MK, Berton DC, Treptow E, Nery LE, Almeida DR, Neder JA.

Am J Physiol Heart Circ Physiol. 2012 Dec 15;303(12):H1474-80. doi: 10.1152/ajpheart.00435.2012. Epub 2012 Sep 28.

Supplemental Content

Loading ...
Support Center